SARS-CoV-2 antibodies. After full immunization with two doses of the mRNA BNT162b2 vaccine, all HD developed anti-S1 IgG and anti-S1 IgA, with levels rising significantly after the booster dose. Here, CD79A is linked to Huntington disease.